This company has been marked as potentially delisted and may not be actively trading. Oaktree Acquisition (OAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock OAC vs. SHLT, IRTC, ALKS, NARI, BLCO, TMDX, ADMA, ITGR, RDNT, and AKROShould you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include SHL Telemedicine (SHLT), iRhythm Technologies (IRTC), Alkermes (ALKS), Inari Medical (NARI), Bausch + Lomb (BLCO), TransMedics Group (TMDX), ADMA Biologics (ADMA), Integer (ITGR), RadNet (RDNT), and Akero Therapeutics (AKRO). These companies are all part of the "medical" sector. Oaktree Acquisition vs. Its Competitors SHL Telemedicine iRhythm Technologies Alkermes Inari Medical Bausch + Lomb TransMedics Group ADMA Biologics Integer RadNet Akero Therapeutics Oaktree Acquisition (NYSE:OAC) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment. Is OAC or SHLT more profitable? Company Net Margins Return on Equity Return on Assets Oaktree AcquisitionN/A N/A N/A SHL Telemedicine N/A N/A N/A Which has more volatility and risk, OAC or SHLT? Oaktree Acquisition has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Do institutionals and insiders hold more shares of OAC or SHLT? 47.6% of Oaktree Acquisition shares are owned by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings & valuation, OAC or SHLT? Oaktree Acquisition has higher earnings, but lower revenue than SHL Telemedicine. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree AcquisitionN/AN/A$1.15MN/AN/ASHL Telemedicine$55.94M0.60-$7.06MN/AN/A Does the media prefer OAC or SHLT? In the previous week, Oaktree Acquisition's average media sentiment score of 0.00 equaled SHL Telemedicine'saverage media sentiment score. Company Overall Sentiment Oaktree Acquisition Neutral SHL Telemedicine Neutral SummaryOaktree Acquisition beats SHL Telemedicine on 3 of the 4 factors compared between the two stocks. Get Oaktree Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OAC vs. The Competition Export to ExcelMetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE ExchangeMarket Cap$1.22B$33.61M$5.47B$20.52BDividend YieldN/AN/A5.25%3.76%P/E RatioN/AN/A27.0027.79Price / SalesN/A0.60435.7540.48Price / Cash377.4554.0336.8222.26Price / Book242.100.397.984.58Net Income$1.15M-$7.06M$3.16B$982.91M Oaktree Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACOaktree AcquisitionN/A$48.42+0.9%N/A+130.9%$1.22BN/A0.00N/AHigh Trading VolumeSHLTSHL TelemedicineN/A$2.05flatN/AN/A$33.61M$55.94M0.00583IRTCiRhythm Technologies1.0446 of 5 stars$145.95-5.2%$138.60-5.0%+39.9%$4.92B$591.84M-46.482,000News CoverageALKSAlkermes4.9317 of 5 stars$28.99+1.3%$40.00+38.0%+20.3%$4.72B$1.56B13.871,800Positive NewsNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800BLCOBausch + Lomb3.1036 of 5 stars$13.45+3.4%$15.54+15.6%-6.0%$4.60B$4.79B-13.0613,500Analyst ForecastTMDXTransMedics Group1.5321 of 5 stars$130.10-2.9%$127.33-2.1%-17.8%$4.53B$441.54M95.66210ADMAADMA Biologics4.1316 of 5 stars$17.88-1.8%$27.67+54.7%+56.0%$4.35B$426.45M21.04530Positive NewsITGRInteger3.647 of 5 stars$121.46-1.2%$145.00+19.4%+0.6%$4.29B$1.72B57.5611,000RDNTRadNet4.2134 of 5 stars$55.62-2.3%$69.60+25.1%-7.3%$4.27B$1.83B-129.3511,021Positive NewsAKROAkero Therapeutics3.4365 of 5 stars$51.41-3.7%$82.50+60.5%+140.2%$4.25BN/A-26.3630 Related Companies and Tools Related Companies SHL Telemedicine Competitors iRhythm Technologies Competitors Alkermes Competitors Inari Medical Competitors Bausch + Lomb Competitors TransMedics Group Competitors ADMA Biologics Competitors Integer Competitors RadNet Competitors Akero Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OAC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredElon brings 'disruption and chaos ' to DCWhat it's really like to work with Elon... "A business partner of mine has close ties to the Department of ...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OAC Stock Alerts